The European Commission (EC) has approved catumaxomab, making it the only approved drug therapy for malignant ascites (MA) for patients living with this debilitating condition across Europe.

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCERUNDER A LICENSING AGREEMENT, LINDIS HAS GRANTED PHARMANOVIA THE ...

In 1775, 250 years ago, William Withering, a physician practising in Birmingham, learnt of a folk remedy for dropsy involving the use of digitalis from purple foxgloves. He started to use it in his ...

Q: It seems like so many people today have a “beer belly.” Why is this more prevalent now? A: It’s unclear when the term ...

The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 ...

Learn about the groundbreaking research on evidence-based care at Toronto General Hospital Research Institute. Understand the ...

Both cirrhosis and hepatic venous outflow tract obstruction can also manifest as ascites. Patients with extrahepatic portal vein obstruction usually present with bleeding from gastroesophageal ...

It occurs when the liver is unable to process bilirubin properly Ascites, or abdominal swelling, is often linked to advanced liver disease. Fluid buildup in the abdomen may be a sign of cirrhosis ...

M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Malignant Ascites. According to GlobalData, Phase II drugs for Malignant Ascites does not have sufficient ...